Phase Ib/II trial of tisotumab vedotin+/- bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024)

Vergote, Ignace; Concin, Nicole; Mirza Raza, Mansoor; Andreassen Mondrup, Camilla; Lorusso, Domenica; GENNIGENS, Christine; Banerjee, Susana; O'Cearbhaill Eilish, Roisin; Campos, Susana; Nicacio Viana, Leonardo; Eaton, Lamar; O'Malley, David; Soumaoro, Ibrahima; Monk, Bradley

Poster (Scientific congresses and symposiums)

Vergote, Ignace; Concin, Nicole; Mirza Raza, Mansoor et al.

2020 • ASCO

Permalink
https://hdl.handle.net/2268/251482

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Phase Ib-II trial of tisotumab vedotin... poster - CG.jpg

Publisher postprint (2.34 MB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

oncology; tisotumab; metastatic cervical cancer; bevacizumab; pembrolizumab; carboplatin

Disciplines :

Oncology

Author, co-author :

Vergote, Ignace

Concin, Nicole

Mirza Raza, Mansoor

Andreassen Mondrup, Camilla

Lorusso, Domenica

GENNIGENS, Christine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service d'oncologie médicale

Banerjee, Susana

O'Cearbhaill Eilish, Roisin

Campos, Susana

Nicacio Viana, Leonardo

More authors (4 more)

Language :

English

Title :

Phase Ib/II trial of tisotumab vedotin+/- bevacizumab, pembrolizumab, or carboplatin in recurrent or metastatic cervical cancer (innovaTV 205/ENGOT-cx8/GOG-3024)

Publication date :

May 2020

Event name :

ASCO

Event place :

United States

Event date :

May 29-31, 2020

Audience :

International

Available on ORBi :

since 12 October 2020

Statistics

Number of views

84 (6 by ULiège)

Number of downloads

0 (0 by ULiège)

More statistics